NDC 80425-0052

Relafen

Nabumetone 500mg

Relafen is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Advanced Rx Pharmacy Of Tennessee, Llc. The primary component is Nabumetone.

Product ID80425-0052_b1fd7c72-ea6e-7a5e-e053-2995a90a4d01
NDC80425-0052
Product TypeHuman Prescription Drug
Proprietary NameRelafen
Generic NameNabumetone 500mg
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2008-03-01
Marketing CategoryANDA / ANDA
Application NumberANDA078671
Labeler NameAdvanced Rx Pharmacy of Tennessee, LLC
Substance NameNABUMETONE
Active Ingredient Strength500 mg/1
Pharm ClassesCyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 80425-0052-1

60 TABLET, FILM COATED in 1 BOTTLE (80425-0052-1)
Marketing Start Date2008-03-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Relafen" or generic name "Nabumetone 500mg"

NDCBrand NameGeneric Name
73684-100RELAFENNABUMETONE
73684-101RELAFENNABUMETONE
80425-0052RelafenNabumetone 500mg
80425-0053RelafenNabumetone 500mg
80425-0054RelafenNabumetone 500mg
80425-0104RelafenNabumetone 750mg

Trademark Results [Relafen]

Mark Image

Registration | Serial
Company
Trademark
Application Date
RELAFEN
RELAFEN
87702292 not registered Live/Pending
Argent Development Group, LLC
2017-11-29
RELAFEN
RELAFEN
86251872 not registered Dead/Abandoned
Argent Development Group, LLC
2014-04-14
RELAFEN
RELAFEN
73353073 1248125 Dead/Cancelled
Beecham Inc.
1982-03-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.